CDH1 and pancreatic neoplasm: Given the known relationship between ADM and the progression of metastatic cancers, as well as the known tumor suppressor function of E-cadherin in other tissues, pathogenic E-cadherin inactivation may be sufficient to initiate pancreatic cancer.